Incyte’s $750 million buyout of Escient Pharmaceuticals is in a rough patch as a mid-stage chronic hives candidate was ...

Take chronic spontaneous urticaria (CSU), for example. When you have CSU, it means dealing with hives that last for six weeks or more. The condition can be life-altering for people who struggle ...

With unfortunately no curative therapy for chronic spontaneous urticaria (CSU) available for now, the overall goal is to ...

KEY TAKEAWAYS Incyte led S&P 500 decliners Tuesday afternoon after the pharmaceutical firm said it will stop developing one ...

CSU is a chronic inflammatory skin disease driven in part by type 2 inflammation, which causes sudden and debilitating hives and recurring itch. CSU is typically treated with H1 antihistamines ...

Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity More than 300,000 people in the US suffer from chronic spontaneous urticaria (CSU ...